Publications found:
251,903
Sort by:
Pharmaceutical Industry in Japan
US$ 300.00
... you a complete analysis of the Pharmaceutical Industry in Japan. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Japan – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Pharmaceutical Industry in Spain
US$ 300.00
... you a complete analysis of the Pharmaceutical Industry in Spain. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Spain – complete with a SWOT analysis of the leading companies in ...
February 2012
145 pages
Pharmaceutical Industry in South Korea
US$ 300.00
... a complete analysis of the Pharmaceutical Industry in South Korea. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement ... competition in the industry, and the key players in the pharmaceutical industry in South Korea – complete with a SWOT analysis of the leading companies ...
February 2012
100 pages
Pharmaceutical Industry in the Netherlands
US$ 300.00
... . Aruvian’s R’search brings you a complete analysis of the Pharmaceutical Industry in The Netherlands. The report covers a brief profile of the global ... competition in the industry, and the key players in the pharmaceutical industry in the Netherlands – complete with a SWOT analysis of the leading companies ...
February 2012
100 pages
Pharmaceutical Industry in Brazil
US$ 300.00
... a complete analysis of the Pharmaceutical Industry in Brazil. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Brazil – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Pharmaceutical Industry in Norway
US$ 300.00
... a complete analysis of the Pharmaceutical Industry in Norway. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Norway – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Pharmaceutical Industry in Taiwan
US$ 300.00
... a complete analysis of the Pharmaceutical Industry in Taiwan. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Taiwan – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Pharmaceutical Industry in Hungary
US$ 300.00
... a complete analysis of the Pharmaceutical Industry in Hungary. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Hungary – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Pharmaceutical Industry in Belgium
US$ 300.00
... a complete analysis of the Pharmaceutical Industry in Belgium. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Belgium – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Pharmaceutical Industry in Germany
US$ 300.00
... a complete analysis of the Pharmaceutical Industry in Germany. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Germany – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Pharmaceutical Industry in Russia
US$ 300.00
... a complete analysis of the Pharmaceutical Industry in Russia. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Russia – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Pharmaceutical Industry in Czech Republic
US$ 300.00
... complete analysis of the Pharmaceutical Industry in Czech Republic. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement ... in the industry, and the key players in the pharmaceutical industry in Czech Republic – complete with a SWOT analysis of the leading companies ...
February 2012
100 pages
Pharmaceutical Industry in South Africa
US$ 300.00
... complete analysis of the Pharmaceutical Industry in South Africa. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement ... in the industry, and the key players in the pharmaceutical industry in South Africa – complete with a SWOT analysis of the leading companies ...
February 2012
100 pages
Pharmaceutical Industry in Italy
US$ 300.00
... you a complete analysis of the Pharmaceutical Industry in Italy. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Italy – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Competitor Analysis: Anti-Obesity Peptides and Biologics
US$ 262.00
... peptides and biologics as of February 2012. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and ... . In addition, the report lists company-specific R&D pipelines of anti-obesity peptides and biologics. Competitor projects are listed in a tabular format providing ...
February 2012
28 pages
Biosensors in Medical Diagnostics: Market Research Report
US$ 4,500.00
This report analyzes the worldwide markets for Biosensors in Medical Diagnostics in US$ Million by the following Product Segments: Medical Biosensors, Glucose Biosensors, Other Medical Biosensors, Environmental Biosensors, and Other Biosensors. The report provides separate comprehensive analytics for the US, ...
January 2012
423 pages
Gene Amplification Technologies: Market Research Report
US$ 4,500.00
This report analyzes the worldwide markets for Gene Amplification Technologies in US$ Million by the following Product Segments: Polymerase Chain Reaction, and Other ... Corp., QIAGEN N.V, Roche Diagnostics, Rubicon Genomics, and Takara Bio, Inc. Market data and analytics are derived from primary and secondary ...
January 2012
529 pages
Gene Therapy: Market Research Report
US$ 4,500.00
This report analyzes the Global market for Gene Therapy in US$ Million. Annual estimates and forecasts are provided for the period 2009 through ... GenVec, Oxford BioMedica, Shenzhen SiBiono GeneTech Co., Ltd., Transgene, and Vical Inc. Market data and analytics are derived from primary and secondary research. ...
January 2012
459 pages
Gums: Market Research Report
US$ 4,500.00
This report analyzes the worldwide markets for Gums in US$ Million by the following Product Segments: Chewing Gum, and Bubble Gum. The report provides separate ... 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 126 companies including many key and niche ...
January 2012
304 pages
Meeting KOL Needs: What Pharma Needs to Know
US$ 1,445.00
The role of the Key Opinion Leader (KOL) has changed over the past 30 years. And it's about to change again.Once viewed with suspicion by their non-consulting peers, clinicians are now considered less...
January 2012
108 pages
Tiered Pricing Strategies in Emerging Markets
US$ 695.00
For the pharmaceutical industry, emerging markets are dynamic, full of potential and offer solid growth at a time when established markets are contracting. But they also pose a significant problem: ex...
January 2012
93 pages
IPCA - Awaiting Re-rating
US$ 140.00
... visibility in sales growth and margin improvement, the stock simply awaits re-rating. Going forward, earnings will be driven by (1) domestic market ... and FY13 earnings by 5-6%. At current valuation, IPCA trades at a PE of 10x on FY13 earnings. This makes IPCA the cheapest stock available with a sustainable ...
January 2012
5 pages
ROCHE - Erivedge (Vismodegib) approved for Locally Advanced or Metastatic BCC in US
US$ 90.00
... , ROG and Curis jointly announced that the USFDA approved once daily Erivedge, oral, first in class hedgehog inhibitor earlier than ... to be approved for this indication. Erivedge will be available in specialty pharmacies in US within one or two weeks. Roche has the marketing rights for Vismodegib excluding ...
January 2012
5 pages
BMY 4Q-11 Results – Patent expiry pains reflecting in the guidance
US$ 90.00
Post today’s announcement of 4Q-11 results, we reiterate our underperform rating on BMY with a PT of $26. The 2012 EPS guidance range of $1.9 - $2.0 is ... reflective of the towering pressures, while valuation continues to remain soaring. BMY holds a promising HCV pipeline, but seems priced to perfection. Yeryoy ...
January 2012
1 pages
LUPIN - Generic Tricor To Offer a Cushion Against Suprax Generic Erosion
US$ 140.00
... multiple years. In addition, there is a strong likelihood that Lupin may remain the only generic player for some time – something that we have ... for Suprax from FY13 to FY14 and (2) estimating $40m from generic Tricor in FY14 (to be launched in Q4 FY13). We upgrade our target price to Rs.463 by applying ...
January 2012
6 pages
NOVARTIS
US$ 90.00
For the fourth quarter 2011, in line with our expectations, NVS Sales grew 5%, and core EPS advanced 8%. NVS also announced full year dividend for 2011 at CHF 2.25, which translates into a meager 2%, increase, which we think is a dampener. The 2012 guidance as well was lackluster as NVS expects net sales in ...
January 2012
2 pages
Global Telemedicine Market Analysis
US$ 1,200.00
Telemedicine enables in providing interactive healthcare utilizing modern technology and telecommunication. The global telemedicine industry has been growing stupendously over the past few years with...
January 2012
65 pages
Global Genetic Testing Market Analysis
US$ 1,200.00
As the foundation of providing superior healthcare lies in diagnosis, genetic testing represents a highly attractive segment in molecular diagnostics market. Genetic testing is a sophisticated form of...
January 2012
65 pages
Global Cosmeceuticals Market Analysis
US$ 1,400.00
Cosmeceuticals are the latest addition to the health industry and are described as cosmetic products with drug-like benefits. With the rise of more knowledgeable, wealthy, and beauty-conscious class o...
January 2012
70 pages
Outsourcing in Drug Development: The Contract Research (Clinical Trial ) Market
US$ 3,995.00
... can expect growing demand for their services. The demand for new drugs remains unabated, but the cost and need to bring those drugs to ... (AMC), Contract Research Organizations and Others. Main Drivers for Outsourcing in Drug Development How CROs are Meeting the Challenge of Patient Recruitment Discussion ...
January 2012
235 pages
World Market for Gastrointestinal Devices
US$ 3,500.00
... gastrointestinal conditions. There are many factors behind the growth of this market. Cancer is one of leading reasons for surgery with more than ... body simplifies port and tool placement. Kalorama's World Market for Gastrointestinal Equipment provides device marketers, manufacturers and investors with ...
January 2012
200 pages
European Biotechnology Directory 2012 - 2013
US$ 200.00
PDF version is dispatched within twenty-four hours after the purchase. PDF option available starting May, 20 The European Directory of Biotechnology Companies 2012-13 is one of the most comprehensive...
January 2012
USA Biotechnology Directory 2012 - 2013
US$ 200.00
PDF version is dispatched within twenty-four hours after the purchase. The most comprehensive and accurate Directory of companies and executives in the USA biotechnology industry.
January 2012
USA Medical Devices & Diagnostics Companies 2012-2013
US$ 200.00
PDF version is dispatched within twenty-four hours after the purchase. The most comprehensive and accurate Directory of companies and executives in the USA medical devices & diagnostics industry.
January 2012
U.S. Market for Orthopedic Large Joint Reconstructive Devices 2012
US$ 7,495.00
... economic crisis in 2011 has limited the recovery, and will have an uncertain effect on the market for the next several years. Nonetheless, ... individuals and a rising obese demographic. Within the orthopedic large joint reconstruction market,, companies such as Zimmer, DePuy Orthopaedics, Stryker Orthopaedics ...
January 2012
195 pages
U.S. Dental Implants, Final Abutments and Computer Guided Surgery Market 2012
US$ 7,495.00
... following segments: Root-form dental implants Non-root form dental implants Dental implant applications Mini-implants Final abutments including Stock ... detailed analysis of market revenues by device type, market forecasts through 2018, unit sales, average selling prices, market drivers and limiters and ...
January 2012
169 pages
Innovative Technologies And Their Impact on the US Diagnostics Market
US$ 3,880.00
The next ten years will be marked by significant technological developments in health care and biotechnology, which will drastically change the assumptions ... The report explores the impact of the most significant technological developments of the next ten years and their impact on the U.S. in vitro diagnostics ...
January 2012
85 pages
Keeping Our Children Healthy: A Review of Paediatric Care
US$ 2,000.00
... conditions will come in the form of safer formulations and options to control the rising rates of chronic diseases... Euromonitor International’s Keeping Our Children Healthy: A Review of Paediatric Care global briefing examines the size, growth trends and potential opportunities in the Consumer Health ...
January 2012
57 pages
European Markets for Anesthesia, Respiratory and Sleep Apnea Devices 2011
US$ 11,495.00
In 2011, the European Market for Anesthesia, Respiratory and Sleep Management Devices was valued at over $1.4 billion. By 2017, this market is expected to reach almost $2 billion, fueled by growth in the sleep therapy device and ventilator segments, the market ...
January 2012
451 pages
Analyzing Robotics in Healthcare
US$ 500.00
... of functions that these medical robots are capable of. Aruvians Rsearch analyzed the robotic surgery industry through its research report Analyzing Robotics in Healthcare. This research offering ...
January 2012
250 pages
